Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.
暂无分享,去创建一个
[1] J. Cooper,et al. Factor VIII, ABO blood group and the incidence of ischaemic heart disease , 1994, British journal of haematology.
[2] M. Silverberg,et al. Activation of the classical pathway of complement by Hageman factor fragment , 1981, The Journal of experimental medicine.
[3] Jacqueline P Mitchell,et al. Comparison of Novel Hemostatic Factors and Conventional Risk Factors for Prediction of Coronary Heart Disease , 2000, Circulation.
[4] M. Balbi,et al. Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity. , 2005, Thrombosis research.
[5] A. Algra,et al. Procoagulant factors and the risk of myocardial infarction in young women , 2006, European journal of haematology.
[6] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[7] W. Halbmayer,et al. Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery , 1994, Coronary artery disease.
[8] T. Renné,et al. Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.
[9] P. A. von dem Borne,et al. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. , 1995, Blood.
[10] G. Lowe,et al. Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[11] B. Freedman,et al. Factors influencing the time from onset of chest pain to arrival at hospital , 1989, The Medical journal of Australia.
[12] C. Hack,et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. , 1998, The Journal of clinical investigation.
[13] T. Meade,et al. Hageman factor and risk of myocardial infarction in middle-aged men. , 1992, Atherosclerosis.
[14] J. Meijers,et al. Fibrinolysis and the Contact System: A Role for Factor XI in the Down-Regulation of Fibrinolysis , 1999, Thrombosis and Haemostasis.
[15] A. Gruber,et al. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. , 2003, Blood.
[16] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[17] G. Feuerstein,et al. Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice , 2005, Journal of thrombosis and haemostasis : JTH.
[18] N. Brooks,et al. Myocardial infarction with normal coronary arteries and factor XII deficiency. , 1985, British heart journal.
[19] L. Björck,et al. Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases , 1998, Nature Medicine.
[20] J Col,et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.
[21] G. Miller,et al. Epidemiological and Genetic Associations of Activated Factor XII Concentration With Factor VII Activity, Fibrinopeptide A Concentration, and Risk of Coronary Heart Disease in Men , 2000, Circulation.
[22] J. Vandenbroucke,et al. John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study , 1994, British journal of haematology.
[23] B. Lämmle,et al. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. , 2002, Atherosclerosis.
[24] F. Rosendaal,et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. , 2000, The New England journal of medicine.
[25] D. Steinberg,et al. Inherited factor XI deficiency confers no protection against acute myocardial infarction , 2003, Journal of thrombosis and haemostasis : JTH.
[26] F R Rosendaal,et al. Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased , 1998 .
[27] G. Lowe,et al. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study , 1999, British journal of haematology.
[28] P. A. von dem Borne,et al. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. , 1997, The Journal of clinical investigation.
[29] J. Cooper,et al. Risk of coronary heart disease and activation of factor XII in middle-aged men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[30] A. Folsom,et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.
[31] A. Scalvini,et al. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction. , 2009, Scandinavian journal of haematology.
[32] K. Fujikawa,et al. Mechanism of activation of bovine factor XI by factor XII and factor XIIa. , 1980, Biochemistry.
[33] M. Winter,et al. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. , 2004, Thrombosis research.